Does post-transplant treatment with imatinib mesylate inhibit graft-versus-leukemia? Authors' replyCHUNDURI, S; DOBOGAI, L. C; BRUNO, A et al.Leukemia. 2005, Vol 19, Num 3, pp 456-457, issn 0887-6924, 2 p.Article

Stem cell transplantation-harnessing of graft-versus-malignancyANTIN, Joseph H.Current opinion in hematology. 2003, Vol 10, Num 6, pp 440-444, issn 1065-6251, 5 p.Article

Graft-versus-leukemia in chronic lymphocytic leukemiaBEN-BASSAT, I; RAANANI, P; GALE, R. P et al.Bone marrow transplantation (Basingstoke). 2007, Vol 39, Num 8, pp 441-446, issn 0268-3369, 6 p.Article

GVL effect in plasmacytoid DC leukemia/lymphomaKALOYANNIDIS, P; ZOMAS, A; PATERAKIS, G et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 5, pp 961-962, issn 0268-3369, 2 p.Article

The graft versus leukemia response after allogeneic hematopoietic stem cell transplantationRIDDELL, Stanley R; BERGER, Carolina; MURATA, Makoto et al.Blood reviews. 2003, Vol 17, Num 3, pp 153-162, issn 0268-960X, 10 p.Article

Perspectives d'immunothérapie des hémopathies malignes = New strategies in immunotherapy for hematologic malignanciesBUZYN, A; OSTANKOVITCH, M; KEMULA, M et al.Hématologie (Montrouge). 1997, Vol 3, Num 6, pp 518-527, issn 1264-7527Article

Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine modelSHAPIRA, Michael Y; HIRSHFELD, Ester; WEISS, Lola et al.Cancer immunology and immunotherapy. 2005, Vol 54, Num 4, pp 383-388, issn 0340-7004, 6 p.Article

Up-regulated expression in nonhematopoietic tissues of the BCL2A1-derived minor histocompatibility antigens in response to inflammatory cytokines : relevance for allogeneic immunotherapy of leukemiaKLOOSTERBOER, Freke M; VAN LUXEMBURG-HEIJS, Simone A. P; VAN SOEST, Ronald A et al.Blood. 2005, Vol 106, Num 12, pp 3955-3957, issn 0006-4971, 3 p.Article

Données nouvelles sur la thérapie cellulaire = New data on the cellular therapyBOURHIS, Jean-Henri.Hématologie (Montrouge). 2001, Vol 7, Num MAR, pp 22-26, issn 1264-7527, NSArticle

The graft-versus-leukemia effects of allogeneic cell therapyPORTER, D. L; ANTIN, J. H.Annual review of medicine. 1999, Vol 50, pp 369-386, issn 0066-4219Article

Extra-medullary relapse of leukemia following allogeneic bone marrow transplantationAU, W. Y; KWONG, Y. L; LIE, A. K. W et al.Hematological oncology. 1999, Vol 17, Num 2, pp 45-52, issn 0278-0232Article

Adoptive immunotherapy using donor leukocyte infusions to treat relapsed hematologic malignancies after allogeneic bone marrow transplantationDROBYSKI, W. R.Cancer treatment and research. 1999, Vol 101, pp 233-266, issn 0927-3042Article

In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantationFEGAN, C; THOMAS, H; BAILEY-WOOD, R et al.Bone marrow transplantation (Basingstoke). 1995, Vol 16, Num 2, pp 277-281, issn 0268-3369Article

Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitutionNING LI; MATTE-MARTONE, Catherine; SHLOMCHIK, Warren D et al.Blood. 2011, Vol 118, Num 22, pp 5965-5976, issn 0006-4971, 12 p.Article

Soluble lymphotoxin is an important effector molecule in GVHD and GVLMARKEY, Kate A; BURMAN, Angela C; WILSON, Yana A et al.Blood. 2010, Vol 115, Num 1, pp 122-132, issn 0006-4971, 11 p.Article

In pursuit of the allo-immune response in multiple myeloma : where do we go from here?COOK, G; BIRD, J. M; MARKS, D. I et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 2, pp 91-99, issn 0268-3369, 9 p.Article

Mixed allogeneic chimerism and graft-versus-leukemia effects in acute myeloid leukemiaSTORB, R.Leukemia. 2002, Vol 16, Num 4, pp 753-754, issn 0887-6924Article

Complete remission of idiopathic myelofibrosis following donor lymphocyte infusion after failure of allogeneic transplantation : demonstration of a graft-versus-myelofibrosis effectCERVANTES, F; ROVIRA, M; URBANO-ISPIZUA, A et al.Bone marrow transplantation (Basingstoke). 2000, Vol 26, Num 6, pp 697-699, issn 0268-3369Article

Cyclosporine-induced autologous graft-versus-host disease in patients with acute myeloid leukemia undergoing non-myeloablative chemotherapy without progenitor cell reinfusionSTEIN, M; FELDMAN, E; SEITER, K et al.Bone marrow transplantation (Basingstoke). 1999, Vol 24, Num 10, pp 1073-1077, issn 0268-3369Article

Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus : A distinct entity?LEBLOND, V; DAVI, F; CHARLOTTE, F et al.Journal of clinical oncology. 1998, Vol 16, Num 6, pp 2052-2059, issn 0732-183XArticle

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapyGIRALT, S; ESTEY, E; CLAXTON, D et al.Blood. 1997, Vol 89, Num 12, pp 4531-4536, issn 0006-4971Article

Variability of the alloreactive T-cell response to human leukemic blastsDELAIN, M; TIBERGHIEN, P; RACADOT, E et al.Leukemia. 1994, Vol 8, Num 4, pp 642-647, issn 0887-6924Conference Paper

Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-LeukemiaVAGO, Luca; TOFFALORI, Cristina; CICERI, Fabio et al.Seminars in oncology. 2012, Vol 39, Num 6, pp 707-715, issn 0093-7754, 9 p.Article

Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantationALPDOGAN, Onder; ENG, Jeffrey M; MURIGLAN, Stephanie J et al.Blood. 2005, Vol 105, Num 2, pp 865-873, issn 0006-4971, 9 p.Article

Hematopoietic lineage-restricted minor histocompatibility antigen HA-1 in graft-versus-leukemia activity after donor lymphocyte infusionKIRCHER, Brigitte; WOLF, Maria; STEVANOVIC, Stefan et al.Journal of immunotherapy (1997). 2004, Vol 27, Num 2, pp 156-160, issn 1524-9557, 5 p.Article